Financing ·
Alterity Therapeutics Limited entered into an underwriting agreement with MST Financial Services Pty Ltd for the…
ATHEAlterity Therapeutics Ltd
Alterity Therapeutics Limited entered into an underwriting agreement with MST Financial Services Pty Ltd for the exercise of up to 8,400,000 unexercised ATHO listed options expiring on August 31, 2026. The options carry an exercise price of A$0.50 per share. The transaction is expected to raise between approximately A$4.2 million and A$7.96 million before costs, depending on the volume of exercised options. Proceeds will support late-stage clinical development of ATH434 for Multiple System Atrophy (MSA) and general working capital. Alterity Therapeutics Limited operates in the biotechnology industry, developing disease-modifying treatments for neurodegenerative diseases.